Lördag 27 September | 19:18:00 Europe / Stockholm

Prenumeration

Kalender

Est. tid*
2026-02-28 08:00 Bokslutskommuniké 2025
2025-10-21 08:00 Kvartalsrapport 2025-Q3
2025-07-24 - Kvartalsrapport 2025-Q2
2025-06-30 - X-dag ordinarie utdelning PTRK 0.00 SEK
2025-06-27 - Årsstämma
2025-05-13 - Kvartalsrapport 2025-Q1
2025-02-28 - Bokslutskommuniké 2024
2024-11-12 - Kvartalsrapport 2024-Q3
2024-08-13 - Kvartalsrapport 2024-Q2
2024-05-14 - Kvartalsrapport 2024-Q1
2024-05-06 - X-dag ordinarie utdelning PTRK 0.00 SEK
2024-05-03 - Årsstämma
2024-02-29 - Bokslutskommuniké 2023
2023-11-14 - Kvartalsrapport 2023-Q3
2023-08-15 - Kvartalsrapport 2023-Q2
2023-05-04 - X-dag ordinarie utdelning PTRK 0.00 SEK
2023-05-03 - Årsstämma
2023-05-02 - Kvartalsrapport 2023-Q1
2023-02-28 - Bokslutskommuniké 2022
2022-11-07 - Kvartalsrapport 2022-Q3
2022-08-25 - Kvartalsrapport 2022-Q2
2022-05-26 - Kvartalsrapport 2022-Q1
2022-05-04 - X-dag ordinarie utdelning PTRK 0.00 SEK
2022-05-03 - Årsstämma
2022-02-24 - Bokslutskommuniké 2021
2021-10-20 - Kvartalsrapport 2021-Q3
2021-07-28 - Kvartalsrapport 2021-Q2

Beskrivning

LandStorbritannien
ListaFirst North Stockholm
SektorInformationsteknik
IndustriProgramvara
Physitrack är verksamt inom hälsovårdssektorn. Bolaget är specialiserat inom sjukgymnastik. Produktportföljen inkluderar digitala vårderbjudanden till företag via SaaS-lösningar. Utöver huvudverksamheten erbjuds även personlig service och tillhörande kringtjänster. Verksamheten drivs globalt med störst närvaro inom Europa och Nordamerika. Physitrack grundades 2012 och har sitt huvudkontor i London.
2025-09-25 14:15:00

First phase of agreement generates €55,000 of upfront and €24,000 annual recurring revenue, strengthens Physitrack’s presence in direct to consumer offering.

London, UK – September 25, 2025 – Physitrack Plc (Nasdaq First North Premier: PTRK) today announced an agreement with one of the largest insurers in mainland Europe to launch a new consumer-facing self-management and self-triage application for musculoskeletal (MSK) conditions. The first phase of the agreement is valued at €55,000 upfront with an annual recurring subscription fee of €24,000, with revenue recognition expected to commence in the third quarter of 2025. Subsequent phases of the agreement, with additional revenue generation and expanded scope of delivery, commence in Q4 2025 and Q1 2026 respectively.

The solution will enable the insurer’s plan members to proactively screen themselves for MSK-related issues and receive guided escalation either to self-management through Physitrack’s exercise library and patient engagement suite, or directly to physiotherapy care when clinically appropriate.

This agreement builds on a long-standing relationship between Physitrack and the insurer, reflecting a shared commitment to empowering patients to take control of their care journey while supporting the insurer in optimising clinical workflows, enhancing patient satisfaction, and managing costs related to physiotherapy.

“We are proud to extend our collaboration with this major European insurer,” said Henrik Molin, CEO and Founder of Physitrack Plc. “It has been a pleasure to evolve our technology together over the years, and this next step brings plan members greater freedom to access the right care at the right time—whether that means self-care or professional physiotherapy support.”

A Spotlight interview segment with CEO and Founder Henrik Molin can be found here:
https://vimeo.com/1117035938/a0eb7ad5ea